OTC Updates
🚨 $EMGE
💰0.0007
Pink Current, AS: 7.5B, OS: 426M, US: 292M
Business Description Updated:
🔴 Emergent curates, develops and sells products in the Regenerative Health Space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. Its subsidiaries; PharmaZu, is a pure play, e-commerce products and service provider focused on the Pet Community, Pet Pharmacy and Pet Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses; Regen BioWellness, is a distributor of various products in the plant-based and regenerative medical fields. Evolutionary Biologics, is a new kind of biologics company founded for a clear purpose: bring cutting edge regenerative products to the medical community. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. For more information, please visit Emergent's Website and Social Media on Twitter. Emergent was founded in 2006 and is now headquartered in New York, NY.
🟢 Emergent has 12 nutritional and dietary products through an exclusive licensing agreement with Cappello’s, Inc., a firm owned by our former President, Dr. John Cappello. These products are based upon the research of Dr. Cappello. These products are, and in the future will be, identified by us based upon suggestions from our distributors, customers and from product and market research we intend to conduct on an ongoing basis. None of these products has been confirmed in any respect by the U.S. Food and Drug Administration or any other governmental agency and may not produce the results intended. In August 2022, we acquired the business of Regen Biowellness, Inc., a distributor of various products in the plant-based and regenerative medical fields. Pursuant to this transaction, we became controlling shareholder of Cannagistics, Inc., a publicly traded company under the symbol “CNGT.” Also in August 2022, we acquired Evolutionary Biologics, Inc., a new kind of biologics company founded for a clear purpose: to bring cutting-edge regenerative products to the medical community. Established in September 2021, Evolutionary is a cutting-edge biotech company with a sophisticated branding and marketing suite. Evolutionary’s products are manufactured at a cGMP-compliant FDA Certified lab using clean rooms and ISO3 and ISO7 technology and produced by highly trained scientists and engineers. As a result, we have total control over all the steps involved in our product development process
Officer(s) Removed:
🔴Marvin Segel, Chief Marketing Officer
Product Services Description Updated:
🔴 Patented and patent pending nutritional supplements VitaStim NeuStem MultiStem Anxium VERAL
🟢 In addition to the products previously offered, Evolutionary offers products that are manufactured at a cGMP-compliant FDA Certified lab using clean rooms and ISO3 and ISO7 technology and produced by highly trained scientists and engineers. Evolutionary’s main products are: • EvoGro - A multi-billion cell count exosomal suspension produced from Wharton’s Jelly (WJ) derived Mesynchemal Stem Cells (MSCs). This product is uniquely positioned for clinical utilization in hair restoration applications. • ExoElixir - A multi-billion cell count dermal fibroblast exosomes suspension enhanced with a proprietary blend of seven (7) natural ingredients that support the repair and overall health of skin tissue. • EvoJel - An ultra-pure and highly concentrated preparation of Wharton’s Jelly (WJ) derived Mesenchymal Stem Cells (MSCs). • EvoHybrid - The only current commercially available combination solution of Wharton’s Jelly (WJ) derived Mesenchymal Stem Cells (MSCs) and amniotic fluid. This is a filtered product, which allows for the safe administration via intravenous (IV) delivery. • EvoMSC - A multi-billion cell count suspension of Wharton’s
t.me/otcupdates
/60453
Nov 8 at 14:44
